Hamish S. Sutherland

Author

University of Auckland

Also Known As

H Sutherland, Hamish S Sutherland, Hamish S. Sutherland, Sutherland, H.S., Sutherland, Hamish S.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Auckland Cancer Society of New Zealand TB Alliance University of Illinois Chicago Maurice Wilkins Centre

About

Hamish S. Sutherland is an author at University of Auckland specializing in pharmacology, organic chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Pharmacology	8	8	481
2	Medicine	6	6	421
3	Biochemistry	6	6	372
4	Chemistry	6	6	325
5	Natural Sciences	5	5	335

Hamish S. Sutherland

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Andrew M. Thompson, Hamish S. Sutherland, Brian D. Palmer, Journal of Medicinal Chemistry Pharmaceutical ScienceOrganic ChemistryAntimicrobial ChemotherapyChemistryHeterocycle Chemistry	2011	109
Synthesis and Structure−Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Brian D. Palmer, Andrew M. Thompson, Hamish S. Sutherland, Journal of Medicinal Chemistry	2009	109
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel Hamish S. Sutherland, Amy S.T. Tong, Peter J. Choi, Bioorganic & Medicinal Chemistry Pharmaceutical Science3,5-Dialkoxypyridine AnaloguesHerg ChannelPharmacotherapyAntimicrobial Chemotherapy	2019	109
Synthesis and Structure−activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains Hamish S. Sutherland, Adrian Blaser, Iveta Kmentová, Journal of Medicinal Chemistry HeterocyclicM. TuberculosisMedicineStructure−activity RelationshipsOrganic Chemistry	2009	89
Synthesis and Structure−Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Iveta Kmentová, Hamish S. Sutherland, Brian D. Palmer, Journal of Medicinal Chemistry	2010	80
6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis Amy S.T. Tong, Peter J. Choi, Adrian Blaser, ACS Medicinal Chemistry Letters	2017	79
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles Hamish S. Sutherland, Amy S.T. Tong, Peter J. Choi, Bioorganic & Medicinal Chemistry	2018	76
Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units Peter J. Choi, Hamish S. Sutherland, Amy S.T. Tong, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ScienceBioorganic ChemistryOrganic ChemistryChemistryHeterocycle Chemistry	2017	57
Structure–Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Adrian Blaser, Brian D. Palmer, Hamish S. Sutherland, Journal of Medicinal Chemistry	2011	56
Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline Adrian Blaser, Hamish S. Sutherland, Amy S.T. Tong, Bioorganic & Medicinal Chemistry	2019	51

Page 1